Market Forecast By Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Others), By Route of Administration (Injectables (Parenteral), Feed, Intra-mammary, Topical, Oral), By Application (Veterinary, Skin Infection, Respiratory diseases, UTI & Pelvic Diseases, Other diseases) And Competitive Landscape
Product Code: ETC312112 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 5 | |
Report Name | Egypt Aminoglycosides Market |
Forecast period | 2025-2031 |
CAGR | 4.6% |
Growing Sector | Healthcare |
Egypt Aminoglycosides Market report thoroughly covers the market by product, by route of administration, and by application. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The Egypt aminoglycosides market is expected to witness significant growth in the coming years due to the rising prevalence of infectious diseases and increasing demand for effective antibiotics. Aminoglycosides are a class of potent antibiotics used to treat severe bacterial infections, including tuberculosis and multidrug-resistant bacteria. These drugs are known for their broad-spectrum activity against a wide range of gram-negative bacteria.
According to 6Wresearch, the Egypt Aminoglycosides Market size is estimated to grow at a CAGR of 4.6% during the forecast period 2025-2031. The increasing prevalence of infectious diseases and the rise of multidrug-resistant bacteria are the major factors driving the growth of the market. Moreover, the growing demand for effective antibiotics and advancements in technology for drug development have also contributed to market growth. However, the high cost of aminoglycoside antibiotics and the availability of alternative treatment options may hinder market growth in Egypt. The Egypt aminoglycosides industry is witnessing several trends that are expected to create new opportunities for existing players and potential entrants. One such trend is the increasing focus on developing novel aminoglycoside antibiotics with improved efficacy and reduced side effects. Additionally, the introduction of combination therapies, where aminoglycosides are used in conjunction with other classes of antibiotics, is also gaining traction in the market.
The Egyptian government has introduced several initiatives to enhance the aminoglycosides market. These measures include increased funding for antibiotic research, optimizing the regulatory process for antibiotic approval, and implementing stringent guidelines to curb antibiotic resistance. The government also promotes awareness campaigns about the prudent use of antibiotics among healthcare professionals and the public.
There are several key players in the Egypt aminoglycosides market, including local and international pharmaceutical companies. Some of the major players include Pfizer Inc., Novartis International AG, Sanofi S.A., and GlaxoSmithKline plc. Furthermore, local pharmaceutical companies such as Eva Pharma, Amoun Pharmaceutical Company S.A.E., and Pharco Pharmaceuticals are also important players in the Egypt aminoglycosides market.
The Egypt aminoglycosides market growth is poised to evolve with technological advancements and increased government intervention. The development of new antibiotics that are more effective against resistant bacteria, combined with improvements in diagnostic testing, will likely drive further growth. In addition, the strategic expansion of key players into emerging markets and the potential for public-private partnerships hold promising prospects for the future of this market.
According to Dhaval, Research Manager, 6Wresearch, Neomycin is currently the only product demonstrating significant growth. Neomycin's rise in popularity can be attributed to its efficacy in treating a broad range of bacterial infections, as well as its relative affordability compared to other aminoglycosides.
Based on the application, the veterinary sector is expected to be the only application area of aminoglycosides that will continue to see growth in the Egypt market. This can be attributed to increasing concerns over animal health and welfare, leading to higher demand for effective antibiotic treatments.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Aminoglycosides Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Aminoglycosides Market - Industry Life Cycle |
3.4 Egypt Aminoglycosides Market - Porter's Five Forces |
3.5 Egypt Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Egypt Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Egypt Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Egypt Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Egypt |
4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating infections |
4.2.3 Rise in healthcare expenditure and infrastructure development in Egypt |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for aminoglycosides approval and usage |
4.3.2 Potential side effects and toxicity associated with aminoglycosides |
4.3.3 Competition from alternative antibiotics and antimicrobial agents |
5 Egypt Aminoglycosides Market Trends |
6 Egypt Aminoglycosides Market, By Types |
6.1 Egypt Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Egypt Aminoglycosides Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Egypt Aminoglycosides Market Revenues & Volume, By Neomycin, 2021 - 2031F |
6.1.4 Egypt Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021 - 2031F |
6.1.5 Egypt Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021 - 2031F |
6.1.6 Egypt Aminoglycosides Market Revenues & Volume, By Amikacin, 2021 - 2031F |
6.1.7 Egypt Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.1.8 Egypt Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021 - 2031F |
6.1.9 Egypt Aminoglycosides Market Revenues & Volume, By Others, 2021 - 2031F |
6.1.10 Egypt Aminoglycosides Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Egypt Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Egypt Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021 - 2031F |
6.2.3 Egypt Aminoglycosides Market Revenues & Volume, By Feed, 2021 - 2031F |
6.2.4 Egypt Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021 - 2031F |
6.2.5 Egypt Aminoglycosides Market Revenues & Volume, By Topical, 2021 - 2031F |
6.2.6 Egypt Aminoglycosides Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3 Egypt Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Egypt Aminoglycosides Market Revenues & Volume, By Veterinary, 2021 - 2031F |
6.3.3 Egypt Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021 - 2031F |
6.3.4 Egypt Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021 - 2031F |
6.3.5 Egypt Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021 - 2031F |
6.3.6 Egypt Aminoglycosides Market Revenues & Volume, By Other diseases, 2021 - 2031F |
7 Egypt Aminoglycosides Market Import-Export Trade Statistics |
7.1 Egypt Aminoglycosides Market Export to Major Countries |
7.2 Egypt Aminoglycosides Market Imports from Major Countries |
8 Egypt Aminoglycosides Market Key Performance Indicators |
8.1 Antibiotic resistance rates in Egypt |
8.2 Number of new product launches or approvals in the aminoglycosides segment |
8.3 Investment in research and development for aminoglycosides innovation |
8.4 Number of healthcare facilities adopting aminoglycosides as a preferred treatment option |
8.5 Patient adherence and compliance rates to aminoglycosides therapy |
9 Egypt Aminoglycosides Market - Opportunity Assessment |
9.1 Egypt Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Egypt Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Egypt Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Egypt Aminoglycosides Market - Competitive Landscape |
10.1 Egypt Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Egypt Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |